Risk of venous thromboembolism and myocardial infarction associated with factor V Leiden and prothrombin mutations and blood type

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt

Standard

Risk of venous thromboembolism and myocardial infarction associated with factor V Leiden and prothrombin mutations and blood type. / Sode, Birgitte F.; Allin, Kristine H.; Dahl, Morten; Gyntelberg, Finn; Nordestgaard, Borge G.

I: C M A J, Bind 185, Nr. 5, 2013, s. E229-E237.

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt

Harvard

Sode, BF, Allin, KH, Dahl, M, Gyntelberg, F & Nordestgaard, BG 2013, 'Risk of venous thromboembolism and myocardial infarction associated with factor V Leiden and prothrombin mutations and blood type', C M A J, bind 185, nr. 5, s. E229-E237. https://doi.org/10.1503/cmaj.121636

APA

Sode, B. F., Allin, K. H., Dahl, M., Gyntelberg, F., & Nordestgaard, B. G. (2013). Risk of venous thromboembolism and myocardial infarction associated with factor V Leiden and prothrombin mutations and blood type. C M A J, 185(5), E229-E237. https://doi.org/10.1503/cmaj.121636

Vancouver

Sode BF, Allin KH, Dahl M, Gyntelberg F, Nordestgaard BG. Risk of venous thromboembolism and myocardial infarction associated with factor V Leiden and prothrombin mutations and blood type. C M A J. 2013;185(5):E229-E237. https://doi.org/10.1503/cmaj.121636

Author

Sode, Birgitte F. ; Allin, Kristine H. ; Dahl, Morten ; Gyntelberg, Finn ; Nordestgaard, Borge G. / Risk of venous thromboembolism and myocardial infarction associated with factor V Leiden and prothrombin mutations and blood type. I: C M A J. 2013 ; Bind 185, Nr. 5. s. E229-E237.

Bibtex

@article{f712e1e5f5b648b09caff33ef92d0201,

title = "Risk of venous thromboembolism and myocardial infarction associated with factor V Leiden and prothrombin mutations and blood type",

abstract = "ABO blood type locus has been reported to be an important genetic determinant of venous and arterial thrombosis in genome-wide association studies. We tested the hypothesis that ABO blood type alone and in combination with mutations in factor V Leiden R506Q and prothrombin G20210A is associated with the risk of venous thromboembolism and myocardial infarction in the general population.",

author = "Sode, {Birgitte F.} and Allin, {Kristine H.} and Morten Dahl and Finn Gyntelberg and Nordestgaard, {Borge G.}",

year = "2013",

doi = "10.1503/cmaj.121636",

language = "English",

volume = "185",

pages = "E229--E237",

journal = "C M A J",

issn = "0008-4409",

publisher = "Canadian Medical Association",

number = "5",

}

RIS

TY - JOUR

T1 - Risk of venous thromboembolism and myocardial infarction associated with factor V Leiden and prothrombin mutations and blood type

AU - Sode, Birgitte F.

AU - Allin, Kristine H.

AU - Dahl, Morten

AU - Gyntelberg, Finn

AU - Nordestgaard, Borge G.

PY - 2013

Y1 - 2013

N2 - ABO blood type locus has been reported to be an important genetic determinant of venous and arterial thrombosis in genome-wide association studies. We tested the hypothesis that ABO blood type alone and in combination with mutations in factor V Leiden R506Q and prothrombin G20210A is associated with the risk of venous thromboembolism and myocardial infarction in the general population.

AB - ABO blood type locus has been reported to be an important genetic determinant of venous and arterial thrombosis in genome-wide association studies. We tested the hypothesis that ABO blood type alone and in combination with mutations in factor V Leiden R506Q and prothrombin G20210A is associated with the risk of venous thromboembolism and myocardial infarction in the general population.

U2 - 10.1503/cmaj.121636

DO - 10.1503/cmaj.121636

M3 - Journal article

C2 - 23382263

VL - 185

SP - E229-E237

JO - C M A J

JF - C M A J

SN - 0008-4409

IS - 5

ER -

ID: 45523721